Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Doro
Institutions:
Universidade Federal de Minas Gerais,
Fiocruz Minas,
Fundação Oswaldo Cruz
Observed institutions:
Universidade Federal de Minas Gerais,
Fiocruz Minas,
Fundação Oswaldo Cruz
OpenAlex ID:
A5035367280
Improved Canine and Human Visceral Leishmaniasis Immunodiagnosis Using Combinations of Synthetic Peptides in Enzyme-Linked Immunosorbent Assay
2012
·
Míriam Maria Costa
, Marcos Penido
, et al.
·
PLoS neglected tropical diseases
·
65
PDF
Antibody responses induced by Leish-Tec®, an A2-based vaccine for visceral leishmaniasis, in a heterogeneous canine population
2014
·
Miriam C. de Souza Testasicca
, Mariana Silva dos Santos
, et al.
·
Veterinary Parasitology
·
41
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein
2022
·
Julia T. Castro
, Patrick Azevedo
, et al.
·
Nature Communications
·
37
PDF
New Vaccine Formulations Containing a Modified Version of the Amastigote 2 Antigen and the Non-Virulent Trypanosoma cruzi CL-14 Strain Are Highly Antigenic and Protective against Leishmania infantum Challenge
2018
·
Ana Paula M. M. Almeida
, Leopoldo F. M. Machado
, et al.
·
Frontiers in Immunology
·
23
PDF
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
2023
·
Patrick O. Azevedo
, Natália S. Hojo-Souza
, et al.
·
npj Vaccines
·
13
PDF
Neutralizing antibody-independent immunity to SARS-CoV-2 in hamsters and hACE-2 transgenic mice immunized with a RBD/Nucleocapsid fusion protein
2021
·
Julia T. Castro
, Marcílio J. Fumagalli
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
Immunization With a RBD/Nucleocapsid Fusion Protein Promotes Neutralizing Antibody-Independent Resistance to the Wild-Type and the Delta Variant of SARS-CoV-2
2022
·
Julia Castro
, Marcílio J. Fumagalli
, et al.
·
SSRN Electronic Journal
Development of influenza virus expressing the antigenic portion of SARS-Cov-2 S protein as a vaccine to prevent Covid19 and flu
2021
·
Júlia Castro
, Gabriela Caldas
, et al.
·
International Symposium on Immunobiologicals (ISI)
PDF
Designing recombinant MVAs as dual-antigen vector vaccines against SARS-CoV-2
2021
·
Daniel Doro
, Sabrynna Brito
, et al.
·
International Symposium on Immunobiologicals (ISI)
PDF
Show more works
View as search
Works count:
9
Citation count:
181
H-index:
5
I10-index:
5
Year
Topic
Type